These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30427938)

  • 41. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.
    Hu Y; Pertinez H; Ortega-Muro F; Alameda-Martin L; Liu Y; Schipani A; Davies G; Coates A
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4778-85. PubMed ID: 27216065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimizing the clinical pharmacology of tuberculosis medications.
    Egelund EF; Alsultan A; Peloquin CA
    Clin Pharmacol Ther; 2015 Oct; 98(4):387-93. PubMed ID: 26138226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
    Williams KN; Brickner SJ; Stover CK; Zhu T; Ogden A; Tasneen R; Tyagi S; Grosset JH; Nuermberger EL
    Am J Respir Crit Care Med; 2009 Aug; 180(4):371-6. PubMed ID: 19520903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic investigational new drugs for the treatment of tuberculosis.
    Kwon YS; Koh WJ
    Expert Opin Investig Drugs; 2016; 25(2):183-93. PubMed ID: 26576631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
    Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
    J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention.
    Nguyen TVA; Anthony RM; Bañuls AL; Nguyen TVA; Vu DH; Alffenaar JC
    Clin Infect Dis; 2018 May; 66(10):1625-1630. PubMed ID: 29126225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bedaquiline: finding the pores on the pot.
    Salfinger M; Migliori GB
    Eur Respir J; 2015 Jul; 46(1):289-91. PubMed ID: 26130783
    [No Abstract]   [Full Text] [Related]  

  • 50. Bedaquiline: finding the pores on the pot.
    Mohapatra PR
    Eur Respir J; 2015 Jul; 46(1):288-9. PubMed ID: 26130782
    [No Abstract]   [Full Text] [Related]  

  • 51. Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Jaspard M; Elefant-Amoura E; Melonio I; De Montgolfier I; Veziris N; Caumes E
    Emerg Infect Dis; 2017 Oct; 23(10):1731-2. PubMed ID: 28792382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Present and future in the use of anti-tubercular drugs].
    Didilescu C; Craiova UM
    Pneumologia; 2011; 60(4):198-201. PubMed ID: 22420168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model.
    Baijnath S; Moodley C; Ngcobo B; Singh SD; Kruger HG; Arvidsson PI; Naicker T; Pym A; Govender T
    Int J Antimicrob Agents; 2018 Jan; 51(1):77-81. PubMed ID: 28843822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in
    Irwin SM; Prideaux B; Lyon ER; Zimmerman MD; Brooks EJ; Schrupp CA; Chen C; Reichlen MJ; Asay BC; Voskuil MI; Nuermberger EL; Andries K; Lyons MA; Dartois V; Lenaerts AJ
    ACS Infect Dis; 2016 Apr; 2(4):251-267. PubMed ID: 27227164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens.
    Walter ND; Born SEM; Robertson GT; Reichlen M; Dide-Agossou C; Ektnitphong VA; Rossmassler K; Ramey ME; Bauman AA; Ozols V; Bearrows SC; Schoolnik G; Dolganov G; Garcia B; Musisi E; Worodria W; Huang L; Davis JL; Nguyen NV; Nguyen HV; Nguyen ATV; Phan H; Wilusz C; Podell BK; Sanoussi ND; de Jong BC; Merle CS; Affolabi D; McIlleron H; Garcia-Cremades M; Maidji E; Eshun-Wilson F; Aguilar-Rodriguez B; Karthikeyan D; Mdluli K; Bansbach C; Lenaerts AJ; Savic RM; Nahid P; Vásquez JJ; Voskuil MI
    Nat Commun; 2021 May; 12(1):2899. PubMed ID: 34006838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
    Wada M
    Kekkaku; 2000 Nov; 75(11):665-73. PubMed ID: 11140090
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration.
    Lounis N; Veziris N; Chauffour A; Truffot-Pernot C; Andries K; Jarlier V
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3543-7. PubMed ID: 16954317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
    Park SW; Tasneen R; Converse PJ; Nuermberger EL
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice.
    Zhao W; Guo Z; Zheng M; Zhang J; Wang B; Li P; Fu L; Liu S
    Int J Antimicrob Agents; 2014 Feb; 43(2):148-53. PubMed ID: 24290060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.